Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

• Hoofdauteurs: Dongxuan Li (Auteur), Chunmeng Qin (Auteur), Hongli Wang (Auteur), Dan Du (Auteur), Yalan Wang (Auteur), Qian Du (Auteur), Songqing Liu (Auteur)
• Formaat: Boek
• Gepubliceerd in: SAGE Publishing, 2024-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between different antineoplastic agents. Objectives: This s...